Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07072533

Effect of Blood Flow Restriction With Aerobic Training on Chest Muscles in Diaplegic Cerebral Palsy

To evaluate the effect of blood flow restriction combined with aerobic training on chest muscle strength in individual with diaplegic cerebral palsy

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cerebral Palsy Spastic Diplegia Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Cerebral Palsy Nervous System Diseases

Age range

12 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

combining blood flow restriction with aerobic training may enhance muscle function and endurance by increasing localized metabolic stress and systemic cardiovascular effects inducing muscular hypertrophy and strength gaining with low load training especially chest muscles which affected in individuals with diaplegic cerebral palsy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diaplegic cerebral palsy. GMFCS level I-III. medically stable.

Exclusion criteria

severe cognitive impairment. cardio respiratory contraindication. previous thoracic surgery or musculoskeletal deformities affecting chest.

Treatment and study plan

Blood Flow Restriction training

Other

individual will do aerobic training .

Other names: aerobic training

Primary outcomes

  1. Chest muscle strength

    Time frame: 3 months

    chest muscle strength will be measured by handheld dynamometry measured in Newton

Secondary outcomes

  1. pulmonary function tests

    Time frame: 3 months

    pulmonary function tests in the form of forced vital capacity and forced expiratory volume in one second will be measured in Liters

  2. sub-maximal aerobic capacity

    Time frame: 3 months

    sub-maximal aerobic capacity will be measured using six minute walk test measured in seconds

  3. quality f life

    Time frame: 3 months

    quality f life will be measured using the pediatric quality of life inventory measured in scores from zero point to four points

  4. oxygen saturation and heart rate response

    Time frame: 3 months

    oxygen saturation and heart rate response will be measured using pulse oximeter measured in percentage for oxygen saturation and pulses per minute for heart rate

Study contacts

Contact information is provided by the study sponsor or research team.

Salah Eid Ahmed Ali, Assis Lect

CONTACT

[email protected]

01158125773

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 18, 2025
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.